• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Management of thyroid cancers.甲状腺癌的管理
Indian J Surg Oncol. 2010 Apr;1(2):151-62. doi: 10.1007/s13193-010-0029-3. Epub 2010 Nov 21.
2
Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan.分化型甲状腺癌伴甲状腺球蛋白升高及阴性诊断性放射性碘全身扫描的处理。
Clin Oncol (R Coll Radiol). 2010 Aug;22(6):438-47. doi: 10.1016/j.clon.2010.05.005. Epub 2010 Jun 18.
3
Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan.放射性碘治疗对分化型甲状腺癌且全身碘扫描阴性患者血清甲状腺球蛋白升高的治疗效果。
Nucl Med Commun. 2006 Jul;27(7):567-72. doi: 10.1097/00006231-200607000-00004.
4
Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.经单侧耳后入路机器人辅助全甲状腺切除术并改良根治性颈清扫术
Ann Surg Oncol. 2014 Nov;21(12):3872-5. doi: 10.1245/s10434-014-3896-y. Epub 2014 Sep 17.
5
Papillary thyroid cancer: medical management and follow-up.乳头状甲状腺癌：医学管理与随访
Curr Treat Options Oncol. 2005 Jul;6(4):323-38. doi: 10.1007/s11864-005-0036-8.
6
[Role of iodine-131 in the management of differentiated thyroid cancers (vesicular origin)].[碘-131在分化型甲状腺癌（滤泡起源）管理中的作用]
Tunis Med. 2002 Aug;80(8):434-44.
7
Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.甲状腺乳头状癌淋巴结复发的临床病理模式。对手术的影响。
Int J Surg. 2014;12 Suppl 1:S194-7. doi: 10.1016/j.ijsu.2014.05.010. Epub 2014 May 23.
8
Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary.颈部超声检查和甲状腺球蛋白抑制对识别接受甲状腺全切除术和放射性碘消融治疗的低风险甲状腺癌患者的复发/持续性疾病具有高敏感性，使得刺激甲状腺球蛋白检测不再必要。
J Ultrasound Med. 2017 Nov;36(11):2299-2307. doi: 10.1002/jum.14260. Epub 2017 May 24.
9
Predictors of thyroid tumor aggressiveness.甲状腺肿瘤侵袭性的预测因素。
West J Med. 1996 Sep;165(3):131-8.
10
Recombinant thyroid-stimulating hormone in differentiated thyroid cancer.重组促甲状腺激素在分化型甲状腺癌中的应用
Isr Med Assoc J. 2001 Nov;3(11):843-9.

本文引用的文献

1
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.美国甲状腺协会修订的甲状腺结节和分化型甲状腺癌患者管理指南。
Thyroid. 2009 Nov;19(11):1167-214. doi: 10.1089/thy.2009.0110.
2
Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal.重组人促甲状腺素辅助放射性碘残留消融术的短期临床复发率与传统甲状腺激素撤药法相似。
J Nucl Med. 2008 May;49(5):764-70. doi: 10.2967/jnumed.107.049072. Epub 2008 Apr 15.
3
Increasing incidence of thyroid cancer in the United States, 1973-2002.1973年至2002年美国甲状腺癌发病率上升情况。
JAMA. 2006 May 10;295(18):2164-7. doi: 10.1001/jama.295.18.2164.
4
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.甲状腺结节和分化型甲状腺癌患者的管理指南
Thyroid. 2006 Feb;16(2):109-42. doi: 10.1089/thy.2006.16.109.
5
Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.2A 型多发性内分泌腺瘤病家系中 RET 密码子 804 突变患者预防性甲状腺切除术的经验。
Clin Endocrinol (Oxf). 2005 Dec;63(6):636-41. doi: 10.1111/j.1365-2265.2005.02394.x.
6
Pediatric thyroid cancer.小儿甲状腺癌
J Surg Oncol. 2005 Nov 1;92(2):130-3. doi: 10.1002/jso.20339.
7
Prognostic variables and calcitonin in medullary thyroid cancer.甲状腺髓样癌的预后变量与降钙素
Laryngoscope. 2005 Aug;115(8):1445-50. doi: 10.1097/01.mlg.0000168114.90852.a6.
8
Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?对于甲状腺球蛋白阳性而131I全身扫描结果阴性的患者，经验性131I治疗是否合理？
J Nucl Med. 2005 Jul;46(7):1164-70.
9
The management of advanced thyroid cancer.晚期甲状腺癌的管理
Clin Oncol (R Coll Radiol). 2004 Dec;16(8):561-8. doi: 10.1016/j.clon.2004.08.009.
10
Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634.患有不影响密码子634的家族性甲状腺髓样癌/多内分泌腺瘤病2A相关RET突变患者的手术时机和范围
World J Surg. 2004 Dec;28(12):1312-6. doi: 10.1007/s00268-004-7640-9. Epub 2004 Nov 4.

甲状腺癌的管理

Management of thyroid cancers.

作者信息

Chaukar Devendra A, Deshmukh Anuja D, Dandekar Mitali R

机构信息

Department of Head and Neck Surgery, Tata Memorial Hospital, Dr. Ernest Borges Road, Mumbai, 400 012 India.

出版信息

Indian J Surg Oncol. 2010 Apr;1(2):151-62. doi: 10.1007/s13193-010-0029-3. Epub 2010 Nov 21.

DOI:10.1007/s13193-010-0029-3
PMID:22930630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3421010/
Abstract

Thyroid cancers cover a large spectrum of disease with diametrically opposite prognosis. At one end of the spectrum we have the well differentiated cancers which carry an excellent prognosis, while at the other end there is anaplastic cancer with high mortality rates and dismal prognosis. Management of thyroid cancers still has some controversial issues due to lack of randomized controlled trials. Extent of surgery, extent of neck dissection, role of radioiodine treatment and thyroid stimulating hormone suppression are still debatable. In this review, we highlight these controversial issues and give guidelines for the management and follow up of patients with thyroid cancer.

摘要

甲状腺癌涵盖了一系列预后截然不同的疾病。在这个范围的一端是分化良好的癌症，其预后极佳，而在另一端则是未分化癌，死亡率高且预后不佳。由于缺乏随机对照试验，甲状腺癌的治疗仍存在一些有争议的问题。手术范围、颈部清扫范围、放射性碘治疗的作用以及促甲状腺激素抑制仍然存在争议。在本综述中，我们强调这些有争议的问题，并给出甲状腺癌患者管理和随访的指南。